EFNA’s latest e-learning series explores Health Technology Assessment (HTA).
Over two modules users can learn what Health Technology Assessment (HTA) is at national and EU level, how it is applied to healthcare decision-making and the viewpoints of the stakeholders involved in the HTA space. The modules cover how the uncertainty around neurological disorders influences current access disparities and how patient involvement can lead to more accurate decision-making in the value chain, ultimately supporting research and innovation and quality of life.
Patient-centred research can help close the gap between unmet medical and unmet patient needs. This course covers the ongoing revisions to HTA regulation at EU-level and the perspectives of payers and industry. You will learn about the progress of patient involvement in HTA processes in Europe, how we compare the USA, the additional challenges for rare neurological conditions, and the PREFER Recommendations on why, when, and how to use patient preferences in medical product evaluation.
These modules are:
- Introduction to Health Technology Assessment, Challenges & Solutions for Neurological Conditions
- Health Technology Access Solutions
EFNA’s e-learning modules are free to access, though registration is required. Participants will be able to access personalised certificates of completion following each module.
Learn more and register at: www.efna.net/elearning
For guidance on registering for and using the e-learning platform you can visit EFNA’s Youtube channel to watch an instructional video.
Development of this e-learning series has been kindly supported by Novartis, Roche and Alexion.